Cover Image
市場調查報告書

DBV Technologies S.A.- 產品平台檢討

DBV Technologies S.A. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 330579
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
Back to Top
DBV Technologies S.A.- 產品平台檢討 DBV Technologies S.A. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 35 Pages
簡介

DBV Technologies S.A.總公司設在法國,進行食物過敏、兒童過敏的診斷及治療用醫藥品的開發。產品有利用非侵入性的經皮給藥技術平台,穩定自動投予抗原的免疫療法用貼片Viaskin。

本報告提供DBV Technologies S.A.的治療藥開發平台的現狀及各開發階段比較分析,各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

目錄

DBV Technologies S.A.的基本資料

  • DBV Technologies S.A.概要
  • 主要資訊
  • 企業資料

DBV Technologies S.A.:R&D概要

  • 主要的治療範圍

DBV Technologies S.A.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

DBV Technologies S.A.:開發中產品概況

  • 在臨床階段的開發中產品
    • 第Ⅱ相的產品/聯合治療模式
    • 第Ⅰ相的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

DBV Technologies S.A.:藥物簡介

  • DBV-712
  • Allergen for Milk Allergy
  • Allergen for House Dust Mite Allergy
  • coagulation factor VIII (recombinant)
  • pertussis vaccine
  • RSV vaccine
  • Drug for Crohn's Disease

DBV Technologies S.A.:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

DBV Technologies S.A.:最近的開發平台資訊

DBV Technologies S.A.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06923CDB

Summary

Global Markets Direct's, 'DBV Technologies S.A. - Product Pipeline Review - 2015', provides an overview of the DBV Technologies S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of DBV Technologies S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of DBV Technologies S.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of DBV Technologies S.A.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the DBV Technologies S.A.'s pipeline products

Reasons to buy

  • Evaluate DBV Technologies S.A.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of DBV Technologies S.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the DBV Technologies S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of DBV Technologies S.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of DBV Technologies S.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of DBV Technologies S.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • DBV Technologies S.A. Snapshot
    • DBV Technologies S.A. Overview
    • Key Information
    • Key Facts
  • DBV Technologies S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • DBV Technologies S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • DBV Technologies S.A. - Pipeline Products Glance
    • DBV Technologies S.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • DBV Technologies S.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • DBV Technologies S.A. - Drug Profiles
    • DBV-712
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Allergen for Milk Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Allergen for House Dust Mite Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • coagulation factor VIII (recombinant)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pertussis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RSV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Crohn's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • DBV Technologies S.A. - Pipeline Analysis
    • DBV Technologies S.A. - Pipeline Products by Target
    • DBV Technologies S.A. - Pipeline Products by Route of Administration
    • DBV Technologies S.A. - Pipeline Products by Molecule Type
    • DBV Technologies S.A. - Pipeline Products by Mechanism of Action
  • DBV Technologies S.A. - Recent Pipeline Updates
  • DBV Technologies S.A. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • DBV Technologies S.A., Key Information
  • DBV Technologies S.A., Key Facts
  • DBV Technologies S.A. - Pipeline by Indication, 2015
  • DBV Technologies S.A. - Pipeline by Stage of Development, 2015
  • DBV Technologies S.A. - Monotherapy Products in Pipeline, 2015
  • DBV Technologies S.A. - Partnered Products in Pipeline, 2015
  • DBV Technologies S.A. - Partnered Products/ Combination Treatment Modalities, 2015
  • DBV Technologies S.A. - Phase II, 2015
  • DBV Technologies S.A. - Phase I, 2015
  • DBV Technologies S.A. - Preclinical, 2015
  • DBV Technologies S.A. - Discovery, 2015
  • DBV Technologies S.A. - Pipeline by Target, 2015
  • DBV Technologies S.A. - Pipeline by Route of Administration, 2015
  • DBV Technologies S.A. - Pipeline by Molecule Type, 2015
  • DBV Technologies S.A. - Pipeline Products by Mechanism of Action, 2015
  • DBV Technologies S.A. - Recent Pipeline Updates, 2015

List of Figures

  • DBV Technologies S.A. - Pipeline by Top 10 Indication, 2015
  • DBV Technologies S.A. - Pipeline by Stage of Development, 2015
  • DBV Technologies S.A. - Monotherapy Products in Pipeline, 2015
  • DBV Technologies S.A. - Partnered Products in Pipeline, 2015
  • DBV Technologies S.A. - Pipeline by Top 10 Target, 2015
  • DBV Technologies S.A. - Pipeline by Top 10 Route of Administration, 2015
  • DBV Technologies S.A. - Pipeline by Top 10 Molecule Type, 2015
Back to Top